Search Results - "duBois, Andreas"

2010 Gynecologic Cancer InterGroup (GCIG) consensus statement on clinical trials in ovarian cancer: report from the Fourth Ovarian Cancer Consensus Conference by Stuart, Gavin C E, Kitchener, Henry, Bacon, Monica, duBois, Andreas, Friedlander, Michael, Ledermann, Jonathan, Marth, Christian, Thigpen, Tate, Trimble, Edward

“…2010 Gynecologic Cancer InterGroup (GCIG) consensus statement on clinical trials in ovarian cancer. This report provides the outcomes from the Fourth Ovarian…”
Get more information

Incidence of Venous Thromboembolism in Patients With Ovarian Cancer Undergoing Platinum/Paclitaxel–Containing First-Line Chemotherapy: An Exploratory Analysis by the Arbeitsgemeinschaft Gynaekologische Onkologie Ovarian Cancer Study Group by FOTOPOULOU, Christina, DUBOIS, Andreas, KARAVAS, Alexandros N, TRAPPE, Ralf, AMINOSSADATI, Behnaz, SCHMALFELDT, Barbara, PFISTERER, Jacobus, SEHOULI, Jalid

“…Venous thromboembolism (VTE) has been associated with negative prognosis in cancer patients. Most series reporting on VTE have included different tumor types…”
Get full text

First-line therapy in ovarian cancer trials by Thigpen, Tate, duBois, Andreas, McAlpine, Jessica, DiSaia, Philip, Fujiwara, Keiichi, Hoskins, William, Kristensen, Gunnar, Mannel, Robert, Markman, Maurie, Pfisterer, Jacobus, Quinn, Michael, Reed, Nick, Swart, Ann Marie, Berek, Jonathan, Colombo, Nicoletta, Freyer, Gilles, Gallardo, Dolores, Plante, Marie, Poveda, Andres, Rubinstein, Lawrence, Bacon, Monica, Kitchener, Henry, Stuart, Gavin C E

“…At the 4th Ovarian Cancer Consensus Conference of the Gynecologic Cancer InterGroup (GCIG) held in Vancouver, Canada, in June 2010, representatives of 23…”
Get more information

European Society of Gynaecological Oncology (ESGO) Guidelines for Ovarian Cancer Surgery by Querleu, Denis, Planchamp, François, Chiva, Luis, Fotopoulou, Christina, Barton, Desmond, Cibula, David, Aletti, Giovanni, Carinelli, Silvestro, Creutzberg, Carien, Davidson, Ben, Harter, Philip, Lundvall, Lene, Marth, Christian, Morice, Philippe, Rafii, Arash, Ray-Coquard, Isabelle, Rockall, Andrea, Sessa, Christiana, van der Zee, Ate, Vergote, Ignace, duBois, Andreas

“…The European Society of Gynaecological Oncology council nominated an international multidisciplinary development group made of practicing clinicians who have…”
Get more information

Vaccination of Patients with Advanced Ovarian Carcinoma with the Anti-Idiotype ACA125 by Reinartz, Silke, Köhler, Siegmund, Schlebusch, Harald, Krista, Karl, Giffels, Patrick, Renke, Kirsten, Huober, Jens, Möbus, Volker, Kreienberg, Rolf, duBois, Andreas, Sabbatini, Paul, Wagner, Uwe

“…Purpose: A Phase I/IIb multicenter study was conducted to evaluate the safety and immunogenicity of the anti-idiotypic antibody vaccine ACA125 that…”
Get full text

Vaccination of patients with advanced ovarian carcinoma with the anti-idiotype ACA125: Immunological response and survival (Phase Ib/II) by REINARTZ, Silke, KÖHLER, Siegmund, SABBATINI, Paul, WAGNER, Uwe, SCHLEBUSCH, Harald, KRISTA, Karl, GIFFELS, Patrick, RENKE, Kirsten, HUOBER, Jens, MÖBUS, Volker, KREIENBERG, Rolf, DUBOIS, Andreas

“…A Phase I/IIb multicenter study was conducted to evaluate the safety and immunogenicity of the anti-idiotypic antibody vaccine ACA125 that functionally…”
Get full text

Evaluation of Potentially Predictive Markers for Anti-Angiogenic Therapy with Sunitinib in Recurrent Ovarian Cancer Patients by Bauerschlag, Dirk O, Hilpert, Felix, Meier, Werner, Rau, Jörn, Meinhold-Heerlein, Ivo, Maass, Nicolai, duBois, Andreas, Sehouli, Jalid, Arnold, Norbert, Schem, Christian, Oberg, Hans-Heinrich, Baumann, Klaus

“…Abstract INTRODUCTION: In ovarian cancer, new therapeutic strategies are needed because the vast majority of patients develop a recurrence and resistance to…”
Get full text

Evaluation of Potentially Predictive Markers for Anti-Angiogenic Therapy with Sunitinib in Recurrent Ovarian Cancer Patients1 by Bauerschlag, Dirk O, Hilpert, Felix, Meier, Werner, Rau, Jörn, Meinhold-Heerlein, Ivo, Maass, Nicolai, duBois, Andreas, Sehouli, Jalid, Arnold, Norbert, Schem, Christian, Oberg, Hans-Heinrich, Baumann, Klaus

“…INTRODUCTION: In ovarian cancer, new therapeutic strategies are needed because the vast majority of patients develop a recurrence and resistance to platinum…”
Get full text

Activity of Pemetrexed (ALIMTA®, Multitargeted Antifolate, LY231514) in Metastatic Breast Cancer Patients Previously Treated with an Anthracycline and a Taxane: An Interim Analysis by Spielmann, Marc, Martin, Miguel, Namer, Moïse, duBois, Andreas, Unger, Clemens, Dodwell, David J.

“…As many breast cancer patients receive adjuvant chemotherapy using anthracyclines or anthracenediones and taxanes, more therapeutic options are needed for…”
Get full text